Key statistics
As of last trade Renalytix PLC (2O9A:STU) traded at 0.226, 8.65% above its 52-week low of 0.208, set on Jul 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.234 |
---|---|
High | 0.244 |
Low | 0.226 |
Bid | 0.226 |
Offer | 0.256 |
Previous close | 0.23 |
Average volume | 0.00 |
---|---|
Shares outstanding | 82.96m |
Free float | 80.05m |
P/E (TTM) | -- |
Market cap | 20.68m USD |
EPS (TTM) | -0.7843 USD |
Data delayed at least 15 minutes, as of Sep 27 2024.
More ▼
Announcements
- Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
- Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
- Medicare Issues Final Coverage Determination for kidneyintelX.dkd
- Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
- Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
- Renalytix Announces Financing with Expected Size of up to $4 Million
- KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)
- Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024
- Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease
More ▼